Clinical Trial Update: Efficacy of Tofacitinib, Methotrexate Combination Therapy Versus Upadacitinib, Methotrexate Combination Therapy in Moderate to Severe Rheumatoid Arthritis [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing tofacitinib with methotrexate versus upadacitinib with methotrexate for moderate to severe rheumatoid arthritis, currently listed as a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• METHOTREXATE (METHOTREXATE)
• Tofacitinib (tofacitinib)
• Upadacitinib (upadacitinib)

Snippet

Sponsor: Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | Conditions: Moderate to Severe Rheumatoid Arthritis | Phase 3 | Status: ACTIVE_NOT_RECRUITING